Profile
GCTK ISRG BDXA BDX RMD ALC
Company Name GlucoTrack, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company ResMed Inc. Alcon Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $4.86M $159.08B $55.91B $53.65B $40.69B $37.85B
Employees 0.01K 15.64K 0.00K 70.00K 9.98K 25.60K
CEO Paul V. Goode Gary S. Guthart - Thomas E. Polen Jr. Michael J. Farrell BE, MBA, SM David J. Endicott
Ratings
GCTK ISRG BDXA BDX RMD ALC
Quant Rating Score 3 3 5 3 4 3
Quant Rating Neutral Neutral Strong Buy Neutral Buy Neutral
Trading
GCTK ISRG BDXA BDX RMD ALC
Last Close $8.09 $443.76 $59.24 $189.08 $277.88 $74.53
High 52 $10.59 $610.45 $59.24 $249.08 $293.73 $98.3
Low 52 $0.06 $433.48 $59.24 $165.15 $204.58 $73.24
Price vs. 52 Week High -23.61 % -27.31 % 0 % -24.09 % -5.4 % -24.18 %
Price vs. 52 Week Low 13383.3 % 2.37 % 0 % 14.49 % 35.83 % 1.76 %
Total Return
GCTK ISRG BDXA BDX RMD ALC
1 Month Return 74.73 % -1.38 % 0 % 0.34 % 2.77 % -4.29 %
3 Month Return 38.77 % -15.65 % 0 % 6.52 % 7.69 % -15.98 %
6 Month Return 4658.82 % -9.35 % 0 % -5.04 % 31.98 % -14.33 %
9 Month Return 6814.53 % -18.94 % 0 % -19.08 % 18.84 % -10.65 %
YTD Return 2068.9 % -14.98 % 0 % -16.66 % 21.51 % -12.2 %
1 Year Return 263.27 % -8.28 % 0 % -19.72 % 16.79 % -22.63 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
GCTK ISRG BDXA BDX RMD ALC
Dividend Yield Percentage (TTM) - - 2.17 % 2.22 % 0.79 % 0.44 %
Dividend Paid and Capex Coverage Ration (TTM) -341.05 % 3.4 % 1.73 % 1.73 % 4.34 % 3.26 %
Dividend Per Share (TTM) - - 4.16 % 4.16 % 2.19 % 0.33 %
Payout Ratio (TTM) - - 73.1 % 73.1 % 22.19 % 15.71 %
Profitability
GCTK ISRG BDXA BDX RMD ALC
Gross Profit Margin TTM -70.83 % 66.65 % 45.08 % 45.08 % 59.36 % 55.13 %
Return on Assets TTM -128.34 % 12.93 % 2.93 % 2.93 % 17.14 % 3.42 %
Return on Equity TTM 1817.48 % 15.57 % 6.31 % 6.31 % 25.51 % 4.93 %
Return on Capital Employed TTM -425.02 % 14.26 % 5.78 % 5.78 % 23.55 % 4.98 %
Net Income Per EBT TTM 100 % 87.46 % 83.91 % 83.91 % 83.5 % 85.57 %
EBT Per Ebit TTM 43.27 % 113.2 % 70.86 % 70.86 % 99.54 % 86.96 %
EBIT Per Revenue TTM -126179.17 % 28.8 % 12.63 % 12.63 % 32.75 % 14.38 %
Cash Flow To Debt Ratio TTM -5364.79 % - 16.82 % 16.82 % 198.52 % 39.27 %
Receivables Turnover TTM - 6.56 7.27 7.27 5.48 4.98
Payables Turnover TTM 0.02 11.43 1.85 1.85 7.52 5.03
Inventory Turnover TTM - 1.83 2.97 2.97 2.25 1.88
Fixed Asset Turnover TTM 18.05 % 183.44 % 313.67 % 313.67 % 716.47 % 197.54 %
Asset Turnover TTM 0.24 % 45.35 % 38.95 % 38.95 % 62.96 % 31.94 %
Operating Cash Flow Per Share TTM -28.97 7.88 11.3 11.3 11.96 4.16
Free Cash Flow Per Share TTM -29.05 5.56 8.85 8.85 11.32 3.23
Cash Per Share TTM 1932.24 % 1485.77 % 262.85 % 262.85 % 825.72 % 284.33 %
Operating Cash Flow Sales Ratio TTM -59683.33 % 30.9 % 15.22 % 15.22 % 34.04 % 20.57 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.29 % 70.57 % 78.37 % 78.37 % 94.7 % 77.51 %
Cash Flow Coverage Ratios TTM -5364.79 % - 16.82 % 16.82 % 198.52 % 39.27 %
Price To Free Cash Flows Ratio TTM -0.34 79.77 21.58 21.04 24.53 23.68
Price To Operating Cash Flows Ratio TTM -0.3 56.29 16.99 16.57 23.24 18.38
Price Cash Flow Ratio TTM -0.3 56.29 16.99 16.57 23.24 18.38
Income Statement (TTM)
GCTK ISRG BDXA BDX RMD ALC
Revenue $0B $8.35B $20.18B $20.18B $5.15B $9.91B
Gross Profit $-0B $5.63B $9.13B $9.13B $3.05B $5.51B
Gross Profit Ratio 0% 67.46% 45.22% 45.22% 59.36% 55.61%
EBITDA $-0.02B $2.81B $4.82B $4.82B $1.91B $2.68B
Net Income $0.02B $2.32B $1.71B $1.71B $1.4B $1.02B
EPS Diluted 60.76 6.42 5.86 5.86 9.51 2.05
Balance Sheet (MRQ)
GCTK ISRG BDXA BDX RMD ALC
Long Term Debt $0B $0.11B $18.61B $18.61B $0.81B $4.97B
Total Liabilities $0.02B $2.31B $31.4B $31.4B $2.21B $8.79B
Total Equity $-0.01B $16.53B $25.89B $25.89B $5.97B $21.55B
Total Investments $0B $7.05B $0.45B $0.45B $0.09B $0.91B
Total Debt $0B $0.15B $20.92B $20.92B $0.88B $5.14B
Total Assets $0.01B $18.84B $57.29B $57.29B $8.17B $30.35B
Cash Flow Statement (TTM)
GCTK ISRG BDXA BDX RMD ALC
Net Income $-0.02B $2.34B $1.71B $1.71B $1.4B $1.02B
Inventory $0B $-0.83B $0.1B $0.1B $-0.08B $-0.05B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.31B $-0.13B
Operating Cash Flow $-0.01B $2.42B $3.8B $3.8B $1.75B $2.08B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.09B $-0.67B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 74.53
ANGO AngioDynamics, Inc. 11.14
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 130.61
ATRC AtriCure, Inc. 36.47
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 31.73
BAX Baxter International Inc. 22.51
BDX Becton, Dickinson and Company 189.08
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 14.42
BLFS BioLife Solutions, Inc. 27.45
COO The Cooper Companies, Inc. 69.75
DXR Daxor Corporation 12.725
EKSO Ekso Bionics Holdings, Inc. 5.34
FEMY Femasys Inc. 0.6491
Unlock